Impact of Brain Connectome and Personality on Cognitive Rehabilitation in Multiple Sclerosis
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 11/28/2018 |
| Start Date: | November 1, 2017 |
| End Date: | October 20, 2018 |
This study aims to apply baseline MRI and neuropsychological measures to predict patient
responses to behavioral cognitive rehabilitation. Training will take place over 12 weeks, 1
hour per day, 5 days per week.
The investigator hypothesizes the following:
[1a] The investigator expects that individuals with low baseline Conscientiousness will
experience a lower magnitude of overall cognitive improvement following rehabilitation
1. b] The investigator expects the impact of Conscientiousness on fidelity of
rehabilitation will in part be moderated by individual differences in program adherence
and executive function
2. a] The investigator expects that individual differences in structural and functional
connectome disturbances will in part explain differences in participant responses to
cognitive rehabilitation.
This study will also serve to supplement the sample of participants for the current IRB
approved study ((IRB: 603069, Title: A case-control, 5-year follow-up study of
cardiovascular, environmental and genetic risk factors for disease progression in patients
with multiple sclerosis.
responses to behavioral cognitive rehabilitation. Training will take place over 12 weeks, 1
hour per day, 5 days per week.
The investigator hypothesizes the following:
[1a] The investigator expects that individuals with low baseline Conscientiousness will
experience a lower magnitude of overall cognitive improvement following rehabilitation
1. b] The investigator expects the impact of Conscientiousness on fidelity of
rehabilitation will in part be moderated by individual differences in program adherence
and executive function
2. a] The investigator expects that individual differences in structural and functional
connectome disturbances will in part explain differences in participant responses to
cognitive rehabilitation.
This study will also serve to supplement the sample of participants for the current IRB
approved study ((IRB: 603069, Title: A case-control, 5-year follow-up study of
cardiovascular, environmental and genetic risk factors for disease progression in patients
with multiple sclerosis.
The participant will be asked to make a total of two (2) visits, approximately 90 days apart.
Each visit will involve: neuro-performance testing, and self-report questionnaires. Each
study visit is expected to take approximately 1-2 hours. Between the two visits, the
participant will be asked to complete a 12 week, computer-based cognitive training program.
This includes 1 hour of training each day for 5 days each week.
On Visit 1, the participants will undergo a full battery of neuro-performance tasks including
tests and questionnaires that will measure their memory, thinking speed, fatigue, and
personality. This visit is expected to take approximately 1-2 hours. The participants will be
also asked to have a close friend or family member to complete similar surveys. A
self-addressed envelope containing these questionnaires will be provided to take home with
them. The participant will need to pass it onto a close friend or family member to be
completed and mailed back.
In addition, the participant will be asked to take part in the 12 week computerized cognitive
training program. This can be done at home, or anywhere the participant has access to a
computer and internet. This cognitive training has been shown to improve cognitive
performance in people with multiple sclerosis. The training involves a variety of interactive
exercises which adapt to their abilities. The participants will need complete 1 hour of
training each day, for 5 days each week.
At 90 days, the participant will return for the 1-2 hours' follow-up visit where they will
complete the same cognitive testing and questionnaires which they had completed during visit
1.
All study visits will take place at Buffalo General Hospital. All of the procedures described
above will be performed by a trained member of the research team as part of the research
study.
If an individual is ineligible for participation, their screening information will be
discarded (i.e., shredded). If participants are deemed eligible (either in person or over the
phone), they will be scheduled to come in to the hospital for neuropsychological testing.
Written consent will be obtained prior to administration of tests. As part of the consent
process, participants will be asked for permission to use any data collected as part of the
screening process as well.
Each visit will involve: neuro-performance testing, and self-report questionnaires. Each
study visit is expected to take approximately 1-2 hours. Between the two visits, the
participant will be asked to complete a 12 week, computer-based cognitive training program.
This includes 1 hour of training each day for 5 days each week.
On Visit 1, the participants will undergo a full battery of neuro-performance tasks including
tests and questionnaires that will measure their memory, thinking speed, fatigue, and
personality. This visit is expected to take approximately 1-2 hours. The participants will be
also asked to have a close friend or family member to complete similar surveys. A
self-addressed envelope containing these questionnaires will be provided to take home with
them. The participant will need to pass it onto a close friend or family member to be
completed and mailed back.
In addition, the participant will be asked to take part in the 12 week computerized cognitive
training program. This can be done at home, or anywhere the participant has access to a
computer and internet. This cognitive training has been shown to improve cognitive
performance in people with multiple sclerosis. The training involves a variety of interactive
exercises which adapt to their abilities. The participants will need complete 1 hour of
training each day, for 5 days each week.
At 90 days, the participant will return for the 1-2 hours' follow-up visit where they will
complete the same cognitive testing and questionnaires which they had completed during visit
1.
All study visits will take place at Buffalo General Hospital. All of the procedures described
above will be performed by a trained member of the research team as part of the research
study.
If an individual is ineligible for participation, their screening information will be
discarded (i.e., shredded). If participants are deemed eligible (either in person or over the
phone), they will be scheduled to come in to the hospital for neuropsychological testing.
Written consent will be obtained prior to administration of tests. As part of the consent
process, participants will be asked for permission to use any data collected as part of the
screening process as well.
Inclusion Criteria:
For all subjects:
- males and females above age 18
- fluent in English
- education >9 years
Additional inclusion criteria for MS patients are as follows:
- Clinically definite MS diagnosis
- Expanded Disability Status Scale (EDSS) ≤ 6.5
- MS patients must be relapse-free and stable from the time of their MRI acquired for
the CEG-MS study
- Willing and able to comply with the study procedures for the duration of the trial
Exclusion Criteria:
- history of serious medical or psychiatric illness (other than MS in the patient group)
that may affect cognitive functioning
- color-blindness
- history of developmental disability
- past or current alcohol or substance dependence
- History of major depressive disorder, bipolar disorder, or psychotic disorder
predating the onset of MS
- History of traumatic brain injury as defined by trauma causing loss of consciousness
or transient post-traumatic or retrograde amnesia exceeding 5 min
- Other pathology related to MRI abnormalities
We found this trial at
1
site
Buffalo, New York 14203
Phone: 716-859-7077
Click here to add this to my saved trials
